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Major depressive disorder (MDD) has an enormous impact on global disease burden, affecting 
millions of people worldwide and ranking as a leading cause of disability for almost three 
decades. Past molecular studies of MDD employed bulk homogenates of post-mortem brain 
tissue, obscuring gene expression changes within individual cell types. Here, we used single-
nucleus transcriptomics to examine ~80,000 nuclei from the dorsolateral prefrontal cortex of 
male individuals with MDD (n=17) and healthy controls (n=17). We identified 26 cellular clusters, 
and over 60% of these showed differential gene expression between groups. We found the 
greatest dysregulation in deep layer excitatory neurons and immature oligodendrocyte 
precursor cells (OPCs), contributing almost half (47%) of all changes in gene expression. These 
results highlight the importance of dissecting cell-type specific contributions to the disease, and 
offer opportunities to identify new avenues of research and novel targets for treatment.   
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Major depressive disorder (MDD) is a complex and heterogeneous disorder that affects an 
estimated 300 million people worldwide1. Genetic factors underlying the risk for MDD have 
been investigated using including genome-wide association studies, among other approaches2. 
Although some genetic associations have been detected, it remains a challenge to extract causal 
disease mechanisms from these findings 3. It has been positing that MDD results from 
dysregulation of monoaminergic transmission, largely implicating the serotonergic and 
noradrenergic systems, has dominated the field for several decades. More recently, other 
factors have been associated with MDD, including glutamatergic and GABAergic transmission4, 5, 
glial cell function, including astrocytic and oligodendrocytic contributions6-8, blood-brain barrier 
integrity6, and inflammation9. Given the wide variety of cell types in the brain and their complex 
interactions, investigative approaches with cell-type specificity are especially needed to gain 
insight into psychiatric phenotypes including MDD. 
The interpretation of differential gene expression in bulk brain tissue homogenates is 
complicated by the heterogeneous cellular composition of the sample. Single-cell sequencing 
approaches have revealed that gene expression patterns in the brain are cell type specific, not 
only differentiating major classes of cells such as neuronal and glial cells, but even 
differentiating subtypes of glial cells and neurons10, 11. Therefore, it is difficult to verify whether 
subtle molecular differences observed from tissue homogenates are explained by the disease 
state or by differences in cell type composition between samples12 Recently developed 
techniques for high-throughput single-cell and single-nucleus RNA-sequencing provide a 
solution for addressing this inherent drawback to bulk tissue experiments11, 13. 
High-throughput droplet-based single-nucleus RNA-sequencing (snRNA-seq) allows the profiling 
of thousands of nuclear transcriptomes, by utilizing nucleus-specific barcodes and unique 
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molecular identifiers (UMI) to tag individual RNA molecules. snRNA-seq yields comparable, 
albeit distinct, information14 from single-cell RNA-seq (scRNA-seq), while facilitating the analysis 
of frozen tissues, which are not amenable to the isolation of intact cells. While there has been 
considerable interest in using scRNA-seq and snRNA-seq datasets to gain insight into the 
processes underlying complex brain disorders15-17, very few direct comparisons of single-nucleus 
human brain gene expression has yet been performed in a psychiatric phenotype using high-
throughput technologies. 
Here, we sequenced ~80,000 nuclear transcriptomes from the prefrontal cortex of MDD cases 
and psychiatrically healthy controls and identified cell type specific differentially expressed 
genes. These results point to gene expression changes in predominantly two cell types, 
oligodendrocyte precursor cells and deep layer excitatory neurons. The relationships between 
and functions of the differentially expressed genes from these two cell clusters suggest 
impairments to FGF signalling, steroid hormone receptor cycling, immune function, and altered 
cytoskeletal regulation (related to changes in synaptic plasticity). This approach to snRNA-seq 
can effectively interrogate subtle phenotypes with improved resolution in archived brain tissue, 
and provide novel directions for follow-up studies. 
Results 
To assess the involvement of individual cell types in the pathophysiology of MDD, we examined 
nuclei from the dorsolateral prefrontal cortex (dlPFC), a region implicated in the pathology of 
major depressive disorder18. We used a droplet-based single-nucleus method optimized for use 
with postmortem brain tissue to assess a large number of nuclei. We measured 78,886 nuclei 
from 34 brain samples, half from patients who died during an episode of MDD, and the other 
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half from matched psychiatrically healthy individuals (Table 1, Supplementary Tables 1-3). The 
experimental design is depicted in Fig. 1. On average, we sequenced to a depth of almost 200 
million reads per sample (Supplementary Table 1). Given that glial cells have consistently been 
found to have fewer transcripts than neuronal cells10, 11, we used custom filtering criteria based 
on the distribution of UMIs per nucleus detected to recover a substantial number of glial cells 
(see Methods, Supplementary Fig. 1a-e, Supplementary Table 4). In an initial subset of 20 
subjects, applying our custom filtering increased the total number of cells 1.8–fold but increased 
the number of non-neuronal cells by almost 6-fold (data not shown). More than 90% of the 
nuclei passing these filtering criteria had less than 5% reads from mitochondrially encoded 
genes (Supplementary Fig. 1f). The average gene count across nuclei ranged from 2144 in 
neurons to 1144 genes in glia (Supplementary Table 5). UMI counts were approximately twice 
the gene count for all cell types, as expected for this level of sequencing depth (Supplementary 
Table 5). Between sample groups, there were no significant differences between cases and 
controls in the median gene count per nucleus (t test p=0.12), median UMI count per nucleus (t 
test p=0.14), and number of cells detected per individual (t test=0.07) (Supplementary Table 1). 
Identification of 26 distinct cell types in the dlPFC 
In order to identify different cell types present in the brain samples, we applied unsupervised 
graph-based clustering19 using the first 50 principal components derived from the 2135 most 
variable genes across individual nuclei (Methods, Supplementary Fig. 2a-b). After stringent 
quality control (Methods), we identified 26 distinct clusters (Fig. 2a). Each cluster was annotated 
using a combination of known cell type markers for excitatory and inhibitory neurons, and non-
neuronal cells, including astrocytes, oligodendrocytes, oligodendrocyte precursor cells (OPCs), 
endothelial cells, and microglia (see Methods for full list of markers, Supplementary Table 6, 
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Supplementary Fig. 3a-p). Gene expression patterns specific to cell type clusters were visualised 
using a DotPlot (Fig. 2b), average and median gene expression heatmaps (Supplementary Fig. 
4a-b), and violin plots (Fig. 2c-e) to form a consensus for annotation. 
Refined cell subtypes reflect cortical cellular architecture  
The clusters generated from our data are consistent with those previously reported in snRNA-
seq of human PFC (Supplementary Fig. 5)11. Gene expression patterns previously linked to 
specific cortical layers (see Methods) coincide with our clustering of excitatory cells. In Fig. 2c, 
the genes are arranged from top to bottom in order of their expression across the cortical layers 
(first 17 rows, from the layer I/II to layer VI). There is a gradient of expression of these genes 
across the excitatory clusters. For example, clusters Ex1, Ex4, and Ex7-9 had high expression of 
TLE4 (layer VI specific). Ex1, Ex8, and Ex9 showed concurrent expression of layer V/VI markers 
such as TOX. Ex6 and Ex7 additionally showed expression of the layer IV specific gene RORB. 
HTR2C, which is specific to a subset of layer V neurons, was prominent in Ex1 alone. PCP4, which 
is also layer V specific, was present in Ex1-3, Ex7, and Ex9. Superficial layer (I-III) markers such as 
CUX2 and RASGRF2 were mainly seen in the large cluster, Ex10. Likewise, inhibitory cell types 
demonstrated subtype specific gene expression patterns. For example, In7 was classified as 
inhibitory-parvalbumin because it expressed GAD1 and PVALB, and lacked VIP and SST (Fig. 2d). 
Multiple astrocytic clusters were also identified, and while the typical sub-classification of 
astrocytes is based on their morphology within grey or white matter20, we used only grey matter 
for these samples. As such, based on the higher percentage of GFAP expression in Astros_3 
(38%) compared to Astros_2 (21%), we suspect that Astros_3 is more likely to represent reactive 
astrocytes21 (Supplementary Table 6). 
Reconstruction of oligodendrocyte developmental trajectory  
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We identified five distinct cell type clusters that fell into the oligodendrocyte lineage (OL), 
including two that we classified as OPCs (Fig 2e). OPCs express a characteristic set of markers 
such as PDGFRA and PCDH15, which decline as these cells mature into oligodendrocytes, 
whereas other lineage markers like, OLIG2 or SOX10, are present in both mature and immature 
cells. Given these developmental stage specific markers it was possible to plot a pseudotime 
trajectory22 using gene expression for OPC1, OPC2, Oligos1, Oligos2 and Oligos3. Our result 
indicated that OPC2 were the youngest cells within the dataset followed by OPC1, then Oligos2 
and Oligos3, with Oligos1 being the most mature (Fig.2e, top). The expression of thousands of 
genes varied according to pseudotime (q<0.01). Approximately half of the genes associated with 
pseudotime overlapped in cases and controls (Supplementary Fig. 6a). However, among the 
genes exclusively associated with pseudotime in cases, there was a 2.7–fold enrichment of 
apoptosis signalling in PANTHER23 pathway analysis (FDR p<9.01x10-3), while no enrichment was 
observed in controls. Given that certain stages of oligodendrocyte differentiation are associated 
with heightened susceptibility to apoptosis, this may indicate differences in OL development 
between cases and controls24. To assess the individual profiles of important developmental gene 
markers, we plotted their expression across pseudotime (Supplementary Fig. 6b-i), revealing 
their expected pattern of expression. 
To compare our oligodendrocyte lineage (OL) cells with previously described OL cell types, we 
performed bioinformatic deconvolution (Fig. 2e, bottom). Our OPC2 gene expression profile was 
entirely represented by the “OPCs” gene expression profile from Jäkel et al. (2019)25. The OPC1 
profile also primarily corresponded to the OPCs, but consistent with this cluster being further 
along the pseudotime trajectory, it showed a small correspondence to the COPs (committed 
oligodendrocyte precursors). Our oligodendrocyte clusters showed varying degrees of 
correspondence to the published data, with decreasing overlap to the published “OPCs” 
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expression profile with increasing maturity of the cell type (ranging from 70-11% 
correspondence). Interestingly, among our oligodendrocytes, Oligos3 showed the highest 
correspondence to the ImOlGs (immune oligodendroglia), as defined by Jäkel et al25. The 
“immune gene expression” feature of Oligos3 is highlighted in our hierarchical clustering 
dendrogram (Fig. 1b), in which Oligos3 is located closer to the Micro/Macro cluster compared to 
the other OL clusters.  
Cell type-specific patterns of altered gene expression in MDD 
We set out to assess gene expression differences between cases and controls within each 
cluster. However, one limitation of droplet based single-nucleus technology is the possibility of 
capturing doublet or multiplet nuclei, which we have estimated to be minimal in our case, as 
only 5.2% of captured nuclei were doublets or multiplets, based on a species mixing experiment 
(Supplementary Fig. 1g). This, however, represented a potential confounding factor when 
assessing differential gene expression between groups. We therefore eliminated doublets and 
multiplets from the dataset by calculating the correlation of each cell to the median expression 
value of its assigned cluster (Methods, Supplementary Fig. 7) and cells with low correlation were 
removed (Supplementary Table 7a-b). We also excluded any genes expressed in less than 10% of 
the cells in that cluster. Using only these purified clusters and filtered genes (median 5212 per 
cluster), we performed a differential gene expression analysis (Supplementary Tables 8-31).  
A total of 96 genes (FDR <0.10) were differentially expressed in 16 of the 25 clusters analyzed 
(Fig. 3a) and 45 of those remained significant at FDR<0.05 (12 of 25 clusters). FDR correction 
considering all clusters together yields 41 significant genes (FDR < 0.10) in 16 clusters 
(Supplementary Table 32). This further supports that our statistical analyses are in fact able to 
detect differences in gene expression between the groups. To retain a larger set of genes in 
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order to better capture functional enrichments within individual cell types, we considered all 
genes which passed FDR < 0.10, corrected per cluster. The majority, 83% (80 genes), were 
downregulated in line with findings from previous transcriptomic studies in MDD3, 4. Differential 
expression analysis treated each cell as a sample (Supplementary Fig. 8a-f), but per subject 
contributions were visualized using heatmaps of average gene expression to assess biases in 
subject contributions. Patterns of gene expression averaged by subject reflected the expected 
differences between cases and controls (Supplementary Fig. 9a-p). Thirty-nine of the 96 
differentially expressed genes were found in excitatory cell clusters and, of those, 34 were 
downregulated (Fig. 3a, insert). Some neuronal clusters contained both upregulated and 
downregulated genes, but it was more common for affected neuronal clusters to contain only 
downregulated genes (8/12, 67%). All but one inhibitory cluster showed altered gene expression 
and non-neuronal clusters tended to have both up- and downregulated genes (Fig. 3b).  
Of particular interest, two clusters – one composed of immature oligodendrocyte precursor cells 
(OPC2) and one composed of deep layer excitatory neurons (Ex7) – accounted for almost half 
(47%) of the dysregulated genes (Fig. 3c). Finally, two genes were differentially expressed in 
more than one cluster: PRKAR1B showed decreased expression in excitatory clusters Ex7 
(FDR=0.087, FC=0.87) and Ex2 (FDR=0.047, FC=0.82) and TUBB4B in excitatory clusters Ex7 
(FDR=0.079, FC=0.87) and Ex6 (FDR=0.073, FC=0.86).  
Cell type specific DEGs recapitulate published MDD findings 
Three of our DEGs (FADS2, CKB and KAZN) have previously been identified in GWAS of MDD2, 
26.To further compare our DEGs with previously reported findings in MDD we took advantage of 
publically available databases PsyGeNET27 and DisGeNET28. Using PsyGeNET we found that 26 of 
our DEGs have previously been linked to mental illness in the literature. The highest number of 
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associations (22/54 associations) were for depressive disorders, followed by associations for 
schizophrenia spectrum and other psychotic disorders (20/54; Fig. 3d). Using DisGeNET we 
found 15 genes associated with MDD related terms (hypergeometric test, p-value = 0.00029; Fig. 
3e). Hypergeometric tests for overlap between DEGs in individual clusters and genes related to 
depression in DisGeNet revealed a specific enrichment in OPC2 DEGs (p=5.7x10-4, Fig. 3e). 
Interestingly, we found that 67% of these genes were contributed by the OPC2 and Ex7 clusters 
(Fig. 3e). Complete results from PsyGeNET and DisGeNET are presented in Supplementary Table 
33-35. 
Functional implications of cell type specific DEGs 
We used Gene Ontology and Reactome Pathway enrichment analysis to identify the relationship 
of our 96 DEGs to biological functions. There were strong enrichments of Gene Ontology terms 
for neuron projection maintenance (84-fold enrichment; FDR=0.011) and negative regulation of 
long-term synaptic potentiation (75-fold enrichment; FDR=0.012). Both of these terms are 
hierarchically related with the more general term regulation of synaptic plasticity, also enriched 
in the set of 96 genes (9-fold enrichment, FDR=0.012). Reactome Pathways enrichments 
included Kinesins (21.74-fold enrichment; FDR = 6.24x10-4), HSP90 chaperone cycle for steroid 
hormone receptors (15.79-fold enrichment; FDR = 3.4x10-2), and Innate Immune System (3.01-
fold enrichment, FDR=3.29x10-2). A full list of all enrichment analyses performed is provided in 
Supplementary Table 36-41.  
The majority (excluding three: AC133680.1, MEG3, FAM66C) of the DEGs were protein-coding. 
We used STRING network analysis 29 to plot the interactions between these proteins coding 
DEGs. This enabled us to identify common pathways and systems, within which these proteins, 
contributed by different cell types, functionally interact. The overall connectivity between 
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proteins encoded by our DEGs was significantly higher than that expected for a random subset 
of genes (p-value = 3.64x10-4). While distinct genes were dysregulated in different clusters, 
common pathways and biological processes dysregulated across clusters included cytoskeletal 
function, immune system function, and SHR chaperone cycling (Fig. 4a), all of which have been 
previously implicated in MDD 9, 30. 
Interestingly, certain genes were present in multiple pathways and processes, for example 
HSP90AA1 (OPC2) links SHR chaperone cycling, immune system functioning and cytoskeletal 
function (Fig. 4b). Likewise, KIF16B from lower layer neurons (Ex7) and KIF26B and KLC2 in two 
inhibitory cells types (In2 VIP and In3 SST respectively), belong to both the kinesin pathway and 
cytoskeletal function (Fig. 4c). Of note, KAZN, a gene previously associated with MDD26, interacts 
with the KIF16B (Ex7), both of which represent some of the few upregulated genes in the 
dataset. 
Weighted gene co-expression network analysis 
In addition to directly measuring gene expression changes between groups, we performed 
weighted gene co-expression network analysis (WGCNA). To circumvent the challenges posed by 
the sparsity of snRNA-seq data, we performed WGCNA on the average gene expression profile 
for each subject across all cell types and included the percentage contribution of different cell 
types as a correlate. Our results indicated that 5 modules were significantly associated with 
MDD (Supplementary Table 42). 
Four of the 5 modules were also strongly associated with Ex7, representing the highest cluster-
phenotype overlap. We chose to focus on the largest module (blue), which included 2699 genes 
and significantly overlapped with our identified DEGs (Fig. 5a, 44%, p-value = 6.04x10-19, 
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hypergeometric test for overlap). To identify the most connected genes within the blue module, 
we performed a hub gene analysis resulting in 285 hub genes (Fig.5b, see Methods) and plotted 
the top 50, which included 10 DEGs (Fig. 5c). The top term for a Gene Ontology analysis of the 
hub gene list was “neurotransmitter secretion” (8.69-fold enrichment, FDR=7.21 x10-3), 
suggesting a disruption of intercellular communication between neural cells. Furthermore, we 
found that 26 of the 41 DEGs that overlapped with the blue module were also hub genes (p-
value = 4.95 x 10-31, hypergeometric test for overlap). 
Validation of gene expression changes 
We preformed validation of our DEGs using fluorescence-assisted nuclei sorting (FANS) to 
separate broad cell types followed by high-throughput qPCR. As expected, given that the FANS 
fractions are much broader than the single cell clusters, with the 26 clusters combined into 4 
sorted populations, levels of validation varied in part as a function of the relative representation 
of the cluster in the sorted fraction (Supplementary Fig. 10-11, Supplementary Tables 43-46). 
Figure 5 (d) highlights validated genes that overlap with the WGCNA results. 
Intercommunication between lower layer excitatory neurons and oligodendrocyte precursor 
cells 
Next, in order to better understand how cells are interacting, we applied a predictive tool to 
explore the relationship of ligands of one cluster to the receptors expressed in another cluster. 
We focused our analysis on Ex7 and OPC2, the two clusters showing the most DEGs, and with 
the greatest overlap of genes associated with phenotype from the literature and from our 
WGCNA. We found a total of 90 significantly changed ligand-receptor combinations between 
Ex7 and OPC2 after random permutations (p<0.01). Fifty-eight Ex7 ligand to OPC2 receptor (Fig. 
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6a left, Supplementary Table 47a) and 32 OPC2 ligand to Ex7 receptor interactions were altered 
between cases and controls (Fig. 6a right, Supplementary Table 47b). We found significant 
changes to FGF signalling originating from both cell types. Although these results are exploratory 
and need to be interpreted with caution, they are consistent with previous literature implicating 
the FGF system in MDD, and particularly, changes in FGF signalling in OPCs 31, 32 leading to 
depressive phenotypes, and provide an intriguing avenue for future experiments.  
Based on the DEGs found in Ex7 and OPC2, we modeled the potential interaction indicating the 
class of protein and change in expression of the gene (Fig. 6b). To add support to the model we 
selected genes to further study with RNAScope® fluorescence in situ hybridization. Given the 
important change in FGF signalling we chose to investigate FIBP (FGF1 intercellular binding 
protein), KAZN a potential junction protein and HPS90AA1 a co-chaperone involved in stress 
hormone receptor cycling. We found FIBP was downregulated, as expected, in deep layer 
excitatory neurons (Fig. 6c, Unpaired t test, t217=2.5, p=0.013, n= 95 nuclei for cases and 
controls) while KAZN was upregulated in OPCs (Fig. 6d, Unpaired t test, t188=2.7, p=0.007, n=100 
nuclei for controls, n=119 nuclei for cases) and HSP90AA1 was downregulated, also in OPCs (Fig. 
6e, Unpaired t test, t192=2.0, p=0.026, n= 107 nuclei for controls, n= 87 nuclei for cases).  
Discussion 
Our examination of single-nucleus transcriptomes from the dlPFC in MDD revealed 
dysregulation of gene expression in almost 60% of the cell types identified, with a total of 96 
differentially expressed genes. There were prominent gene expression changes in immature 
oligodendrocyte precursor cells (OPC2) and in deep layer excitatory neurons (Ex7), and a large 
percentage of their DEGs overlapped with genes previously implicated in MDD. 
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Given the complexity of psychiatric disorders such as MDD, disentangling the role of each cell 
type in the brain is important and requires single cell resolution. For example, the ability to 
distinguish glial subtypes – including multiple astrocytic, oligodendrocytic, and OPC clusters – 
enabled us to pinpoint changes specific to OPCs, but not oligodendrocytes, and changes 
selective to only one subset of astrocytic cells.  
In recent years, the target cell types in MDD pathophysiology have expanded from excitatory 
neurons to include inhibitory interneurons18 and non-neuronal cells4-9. Here we found 16 unique 
cell types showing evidence of differential gene expression in depression, including 4 non-
neuronal clusters and 6 clusters of interneurons supporting the complex interplay between 
multiple cell types in MDD. Previous studies have shown that SST and PVALB interneurons are 
dysregulated in MDD patients18, and here we report several DEGs in 3 interneuron clusters that 
are defined by the expression of these GABAergic markers (Inhib_3_SST, Inhib_6_SST, and 
Inhib_8_PVALB). Interestingly, a separate cluster of PVALB interneurons (Inhib_7_PVALB) did 
not show differential expression, which may indicate that not all PVALB interneurons are equally 
affected. However, we find differentially expressed genes in non-SST, non-PVALB interneuron 
clusters (Inhib_2_VIP, Inhib_1, and Inhib_5), which suggests that additional interneuron 
subtypes could have a role in depression, and should be examined in future research.  
We found 10 different excitatory cell types which were annotated to specific cortical layers 
based on known markers. Ex10 represented a large cluster of superficial cortical layer cells, 
whereas there were numerous clusters representing different excitatory cell types from deeper 
cortical layers. The neuronal cluster with the most change was Ex7, a deep layer cluster 
characterized primarily by DPP10 expression. DPP10 encodes a dipeptidyl peptidase-related 
protein that regulates neuronal excitability and has previously been associated with a human-
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specific, neuron-based regulatory network. Structural variants of this gene have been implicated 
in neuropsychiatric diseases, including autism, schizophrenia and bipolar disorder33.  
OPC2 also showed extensive gene expression changes between cases and controls. OPC2 was 
the youngest cell type in the OL pseudotime trajectory. The use of cellular deconvolution 
techniques indicated that OPC1 have some similarity to committed OPCs whereas OPC2 showed 
no such correspondence, supporting the idea of functional heterogeneity among OPCs 34. 
Furthermore, compared to OPC1, OPC2 expressed higher levels of certain glutamate and sodium 
receptors, which are typically lost as the cells mature 34. 
Evidence suggests that half of the OPCs (NG2+) in the brain do not give rise to any other cell 
type35, and exhibit synaptic contact with neurons 36. As such, OPCs are now thought to be a 
distinct glial cell type implicated in brain plasticity through roles such as integration of synaptic 
activity37 and mediation of long term potentiation38. Additionally, there is evidence directly 
implicating the loss of this cell type with emergence of depressive-like behaviour31. The data 
from this study support a role for OPCS in MDD independent from their role as precursor cells 
for oligodendrocytes. 
STRING DB protein network analysis highlighted a number of links including connections 
between three differentially expressed genes encoding kinesin-related proteins: KIF26B, KLC2 
and KIF16B. KIF16B (increased in Ex7) is involved in recycling receptors including the fibroblast 
growth factor receptor (FGFR). Interestingly, FIBP, encoding acidic FGF1 intracellular-binding 
protein, was decreased in Ex7. FGFR transport relies, in part, on the interaction between 
kinesins and Rab GTPases 39. Notably, we found RAB11B (encoding a Rab GTPase) and KLC2 to be 
downregulated in In3. Taken together, these finding could point to a disruption of FGFR 
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recycling by kinesins and Rab GTPases, as well as disrupted modulation FGF intercellular 
signalling by FIBP in neurons in MDD.  
Based on animal models and in cell culture, FGFs (specifically FGF2) and FGFRs seem to be 
affected by stress and the glucocorticoids40. The glucocorticoid receptor (GR) has consistently 
been implicated in MDD 41. HSP90AA1 (decreased in OPC2) and FKBP4 (decreased in Ex7), along 
with its homolog FKPB5, encode cochaperones for the GR and regulate intracellular signalling 
functions of this receptor30. HSP90AA1 codes for the stress inducible isoform HSP90α and 
interestingly, is known to be secreted in certain stress contexts 42. These changes may point to a 
fundamental disruption in GR signaling in deep layer excitatory cells and OPCs, which could 
further interact with the above described changes in FGF signalling.  
The genes related to chaperone mediated steroid hormone receptor cycling overlapped with 
genes involved in innate immune function. This is unsurprising given the role of glucocorticoids 
in modulating inflammation, one of the primary responses of the immune system. Both OPC2 
and Ex7 were enriched for the common genes between these pathways. Finally both the FGF 
and GR system have implications in the plastic properties of excitatory neurons such as 
projection outgrowth and stability 43, 44.  
Additionally, genes such as PRNP (the prion protein gene) and KAZN (a gene involved in 
desmosome assembly), were strongly altered in the OPC2 cluster and are associated with 
mediating synaptic plasticity and cellular communication45, 46 . The absence of Prnp has been 
associated with an increased number of undifferentiated oligodendrocytes and the delayed 
expression of differentiation markers47. which is intriguing given the evidence implicating a lack 
of mature adult oligodendrocytes in animal models of depression and anxiety48. On the other 
hand, overexpression of kazrin in keratinocytes profoundly changed cell shape, reduced 
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filamentous actin, and impaired assembly of intercellular junctions 46. Interestingly, decreased 
desmosome length has been described in Prnp−/− mice49 suggesting an interplay between these 
proteins. Further, a SNP in KAZN showed one of the strongest associations in individuals with 
treatment resistant depression 26.  
Based on the information we derived from various bioinformatics strategies we have proposed a 
putative model for the bidirectional interactions between lower layer excitatory neurons and 
immature oligodendrocytes. We used RNAScope® to validate some of the key transcriptional 
changes highlighted by the model. Though these results are interesting, functional follow up 
studies will be required to determine the role of molecules like FGF, HSP90α and Kazrin in the 
communication between these two cell types.  
Our study is not without limitations. All individuals included in our study were male, so our 
results are not necessarily generalizable to women, particularly as previous studies have 
suggested that brain transcriptomic changes associated with MDD are different in females50. 
Nonetheless, this first screen provides important information that may help inform subsequent 
studies exploring both men and women with MDD. Technical limitations with droplet-based 
snRNA-seq of human brain have been previously described. We, like others10, 11, found a much 
greater proportion of neurons compared to glial cells than would be expected based on 
histologically determined estimates, pointing to a potential limitation of the methodology for 
capturing non-neuronal cells. Although droplet-based snRNA-seq does not capture lowly 
expressed genes, nevertheless, we were able to perform differential gene expression for 
thousands of genes in precisely defined cell types. 
Lastly, we believe the consistency across dissections was not sufficient for estimating cell type 
proportions. For example, even a small over-representation of one cortical layer versus another 
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during dissection, can give misleading results regarding the proportion of cell-types. Other 
groups have attempted to extract nuclei from cryo-sectioned samples to address these 
inconsistencies 10. 
Our study has elucidated gene expression changes specific to numerous independent cell types 
in MDD. We have identified a potentially important link between OPCs and deep layer excitatory 
neurons, which implicates fundamental pathways including FGF signalling, glucocorticoid 
receptor regulation and synaptic plasticity in the brains of depressed individuals. The 
generalizability of these data will rely on independent validation in other MDD cohorts; 
nonetheless, this work provides an exciting start point for understanding the complex interplay 
of cells in the brain and a platform for future functional research to assess these potential 
interactions. Future single-cell studies of MDD should aim to relate cell types with 
symptomology and severity as has been done in recent papers 16, 17 . 
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Figure 1: Experimental Flow. Schematic representation of experimental procedures. Nuclei 
were extracted from Brodmann area 9 (BA9) in the dlPFC of 17 cases and 17 controls, single 
nuclei were captured in droplets for RNA-seq. Unsupervised clustering and cell type annotation 
were followed by differential expression analysis between cases and controls within each 
cluster. Bioinformatic analyses were performed to link the changes to the phenotype. Two 
validation approaches: FANS-high-throughput qPCR and FISH, were applied for validating 
differential expression results.  
Figure 2: Identification of cell types a) TSNE plot depicting the ~73,000 cells in 26 clusters 
identified after strict quality control of initial clusters.b) Cell type annotation was performed 
based on expression of well-established marker genes. (Left) Dendrogram representing 
relationship between identified cell type clusters based on gene expression. (Middle) DotPlot 
depicting expression of known marker genes in the 26 clusters of interest. Marker genes are 
colour coded according to the cell type in which they should be detected. The size of the dots 
represents the proportion of cells expressing the gene whereas the colour intensity represents 
the average expression level. (Right) Columns listing the number of cells per group and the bar 
plot depicting the mean number of UMIs per cell in each cluster. c) Cortical layer specific 
markers varied in expression within the excitatory neuronal clusters. The violin plots depict the 
expression per cluster of layer specific marker genes going from the more superficial layers (I/II) 
on the left to the deeper layers (V/VI) on the right. d) Known classes of inhibitory neurons are 
identifiable based on the expression pattern of peptide genes (VIP, SST, CCK) and calcium 
binding protein genes (PVALB). e) (Left, violin plots) Cells belonging to the oligodendrocyte 
lineage expressed the expected markers. (Top) The oligodendrocyte lineage cells from 5 clusters 
were analysed to produce a pseudotime trajectory to gauge their developmental stages. . (Right) 
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The location of these clusters along the trajectory was consistent with deconvolution (Jäkel et 
al., 2019). The numbers represent the percentage contribution of each of the previously 
published cluster signatures to the corresponding clusters in our dataset.  For violin plots in 
figures 2c-e values extend from minimum to maximum, the median value is indicated by a dot 
and the n-value per cluster corresponds to the total “No. of cells”for cases and controls 
combined listed in 2b. Nuclei were derived from 34 subjects. 
Figure 3: Differentially expressed genes. a) For each cluster the percentage change in 
expression between cases and controls of all detected genes are plotted with decreased 
expression to the bottom of the midline and increased expression to the top. Ninety-six 
significantly changed genes (16 were up-and 80 down-regulated) are marked in colour, based on 
their corrected FDRs as shown in the legend. The numbers of nuclei from cases and controls per 
cluster (n) are available in Supplementary Tables 8-31. p-values were obtained using a mixed 
linear model (see Methods). Nuclei were derived from 34 subjects. Sixteen out of the 26 clusters 
contained significantly differentially expressed genes. (Insert) Stacked bar-graph shows 
contribution of different cell type clusters to differentially expressed genes. b) Number of 
clusters in each broad category showing up and downregulated genes in MDD cases. c) The 
scatter plots represent the number of DEGs and the average percentage change in expression 
for each cluster. The cluster size is depicted by the size of the circle. Upper graph depicts 
upregulated genes, lower graph depicts downregulated genes. OPC2 and Ex7 show the highest 
level of both up and down regulated genes. d-e) The number of genes with known relationship 
to psychiatric phenotypes using available databases PsyGeNET and DisGeNET. d) 26 of the 96 




and showed an enrichment for MDD (Total, all the genes which overlap database for a given 
disorder; 100% association, the genes positively associated with the disease; 100% no 
association, the genes negatively associated with the disease; both, mixed findings (positive and 
negative) for a given gene related to the disease. e) (Left) 15 genes were found to be associated 
with depression related terms in DisGeNET.  (Right) The percentage of genes per cluster 
associated with MDD from DisGeNET, along with cluster specific enrichment of DisGeNET MDD 
associated genes. For hypergeometric tests, the number of depression-associated genes in 
DisGeNET was 1199 and the number of unique genes in DisGeNET was 17545 for all tests. The 
number of DEGs in DisGeNET (k) and the number of depression-associated DEGs (x) are listed:  
All clusters: k=85, x=15; OPC2: k=24, x=7; Ex7: k=19, x=3; Endo: k=2, x=1; Astro3: k=6, x=1; Ex3:  
k=2, x=1; In2:  k=11, x=1; In5: k=2, x=1.  
Figure 4: Differential expression and biological associations. a) String DB network for all DEGs 
with nodes corresponding to a set of biological processes and pathways highlighted (legend on 
right). b) Subset of genes shared between the immune function related terms and the steroid 
hormone receptor cycling pathway. c) Subset of genes involved in cytoskeletal function and 
kinesin activity. Colour strips beneath networks give a proportional representation of the 
contributing clusters.  
Figure 5: Weighted gene co-expression network analysis. a) Venn diagram of overlap between 
blue module genes and DEGs (hypergeometric test, p-value = 6.037692e-19). b) Venn diagram 
for overlap between blue module hub genes and DEGs (hypergeometric test, p-value = 
4.954172e-31). c) Visualization of the top 50 hub genes assessed for the blue module. DEG 
nodes and all edges connected to them are colored teal. d) Boxplots represent expression levels 
of DEGs validated with high-throughput qPCR in FAN sorted populations which were also hub 
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genes in the blue module. Mann-Whitney U tests (two-sided) were performed for PRAF2 as the 
values were not normally distributed based on the Shapiro Wilk’s test for normality. All other 
genes were tested with unpaired two-sided t-tests as their values were normally distributed. P-
values: * < 0.05, ** < 0.01, *** < 0.001, **** < 0.0001. Whiskers on box plot represent 
maximum and minimum values.  Box extends from the 25th percentile to 75th percentile, the 
center line represents the median, and dots represent all values in the dataset. ATP6V0B: n=15 
cases, 11 controls, t=3.10, df=12.62, p-value=0.0087; CKB: n=9 cases, 7 controls, t= 2.48, 
df=16.85 p-value= 0.023 ; PRAF2: n=14 cases, 10 controls, U= 8, p-value=6.8 x 10-5; TKT: n= 16 
cases, 14 controls, t= 2.25, df=19.83, p-value=0.036; PLD3: n=15 cases, 14 controls, t= 3.06, df= 
15.83, p-value=0.0075; OTUB1: n=16 cases, 14 controls, t= 2.39, df=20.92, p-value=0.026; ACTB: 
n=14 cases, 15 controls, t=3.14, df= 19.98, p-value=0.0052; HNRNPK: n= 14 cases, 13 controls, 
t=2.41, df=16.07, p-value=0.028.  
Figure 6: Contributions of OPC2 and Ex7.  a) CCInx receptor ligand based cell-cell interaction 
network analysis for communication between Ex7 and OPC2. Given the large number of 
connections (Supplementary Tables 47a,b), a subset are shown. b) Our data points to a change 
in the communication between deep layer excitatory neurons (Ex7) and immature OPCs (OPC2). 
Altered FGF bidirectional signalling was identified via CCInx. We propose that immature OPCs 
have a very important role in regulating plastic properties of deep layer excitatory cells, such as 
neuron projection outgrowth and maintenance. Lines between cell types are labeled with 
secreted or junction proteins found to be dysregulated in the given cell type for example 
HPS90AA1 codes for the stress inducible isoform HSP90α, known to be secreted in certain 
contexts, KAZN is an upregulated junction protein in OPCs and ATP6V0B could represent altered 
ATP signaling. Arrows beside gene names indicate up or downregulation. Beside each cell type 
are the genes in given functional categories and their direction of change in the disease state. c) 
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Decreased expression of the gene encoding FGF1 intercellular Binding Protein (FIBP) was 
validated in deep layer neurons using RNAScope®. SLC17A7 (encoding VGLUT) was used as a 





cells were imaged and FIPB expression was counted (Cases: n=119 nuclei, controls: n=100 nuclei, 
unpaired two-sided t-test, t = 2.49, df= 217, p = 0.013). d) Increased KAZN (cases: n=95 nuclei, 
controls: n=95 nuclei, unpaired two-sided t-test, t = -2.69, df= 188, p = 0.008) and e) decreased 
HSP90AA1 (cases: n = 87 nuclei, controls: n = 107 nuclei, unpaired two-sided t-test, t = 2.23, df= 
186, p= 0.027 expression were validated in OPCs using PDGFRA as a marker for oligodendrocyte 
precursor cells.  Whiskers on box plot represent the 5th and 95th percentile. Box extends from 
the 25th percentile to 75th percentile and the center line represents the median. Dots represent 






Table 1: Sample information 
 
Controls (n=17)  Cases (n=17) p value 
Age (years) 38.71 ± 4.32 41.06 ± 4.66 p=0.714 
Gender 17M 17M - 
PMI (hrs) 34.01 ± 4.94 41.69 ± 4.76 ᵻp=0.190 
pH 6.49 ± 0.06 6.60 ± 0.07 p=0.212 
Storage Time (years) 14.71± 1.44 12.47± 1.46 ᵻp=0.543 
Cause of death 
Accident (6),  
Natural (11) 
Suicide (17)  
Substance 
dependence 
None None  
Comorbid diagnoses None None  
Toxicology 
EtOH (2), 
Cannabinoids (1),  
EtOH (6), BZ (1), AD 
(2), Cannabinoids (1), 





None 3  
Mean ± SEM 
ᵻMann Whitney test 









Materials and Methods 
Subjects: Postmortem brain samples 
This study was approved by the Douglas Hospital Research Ethics Board, and written informed 
consent from next-of-kin was obtained for each subject. Postmortem brain samples were 
provided by the Douglas-Bell Canada Brain Bank (www.douglasbrainbank.ca). Frozen grey 
matter samples were dissected from Brodmann Area 9 (dlPFC). Brains were dissected by trained 
neuroanatomists and stored at -80 C. For each individual, the cause of death was determined 
by the Quebec Coroner’s office, and psychological autopsies were performed by proxy-based 
interviews, as described previously51. Cases met criteria for MDD and died by suicide whereas 
controls were individuals who died suddenly and did not have evidence of any axis I disorders 
(Table 1). Post mortem interval (PMI) represents the delay between a subject’s death and 
collection and processing of the brain.  To assess RNA quality, we measured the RIN obtained for 
our samples using tissue homogenates. An unpaired, two-tailed, Student’s t-test revealed no 
significant difference (p=0.15) in RIN between cases (mean RIN of 6.74) and controls (mean RIN 
of 6.16). 17 cases and 17 controls were included in the snRNA-seq experiment and the full 
cohort of subjects (except 25) was used for follow-up validation of DEGs by FANS and high 
throughput qPCR. RNAScope experiments were performed on representative subsets of samples 
using 5 cases and 5 matched controls. Detailed information on experimental design and 
reagents can also be found in the Life Sciences Reporting Summary. 
Nuclei isolation and capture 
50 mg of frozen tissue was dounced in 3 mL of lysis buffer, 10 times with a loose pestle and an 
additional 5 times with the tight pestle. The lysis buffer contained 10 mM Tris (pH 7.4), 10 mM 




mL of buffer for 5 min, after which 5 mL of wash buffer was added and swirled. The sample was 
passed through a 30 μm cell strainer and spun for 5 min at 500 g. This step was repeated for a 
total of two filtering steps. After pelleting, the nuclei are resuspended in 5-10 mL of wash buffer 
by pipetting up and down 8-10 times. After 3 washes, the nuclei were resuspended in 1 mL of 
wash buffer and mixed with 25 % Optiprep™ and layered on a 29 % Optiprep™ cushion and spun 
for 30 min at 10,000 g. Nuclei were resuspended in wash buffer to achieve a concentration of 
~1x106 nuclei/mL. Representative images of extracted nuclei are presented in Supplementary 
Fig. 12.   
We used the 10x Genomics® Chromium™ controller for single cell gene expression to isolate 
single nuclei for downstream bulk RNA library preparation. We strictly followed the protocol as 
outlined by the user guide (CG00052_SingleCell3_ReagentKitv2UserGuide_RevE.pdf), with the 
exception of loading concentration, which we increase by 30% as we assessed the capture of 
nuclei to be slightly less efficient than cell encapsulation. We aimed to capture ~3000 nuclei per 
sample. So, for example, if our sample concentration was 390 nuclei/μL (~ 400 nuclei/ μL) 
according to page 10 of Protocol Step 1 we are required to load 13.1 μL of the stock to capture 
3000 cells. But instead, we would recalculate our stock concentration to be 70% of 390 = 273 
nuclei/ μL and load 17.4 μL (the recommended amount for 300 nuclei/ μL) instead. This system 
only allows for a maximum of 8 samples per capture run. As such, we required multiple batches 
to collect the individual nuclei for all 34 samples (6 batches). Samples 24 and 25 performed 
poorly, we therefore, carried out the capture on two separate chips and sequenced twice 
combining the data from both runs for the final analysis.  




A pre-mRNA transcriptome was built using the cellranger mkref (Cellranger version 2.0.1) 
command and default parameters starting with the refdata-cellranger-GRCh38-1.2.0 
transcriptome and as per the instructions provided on the 10X Genomics website. Reads were 
demultiplexed by sample index using the cellranger mkfastq command (Cellranger v2.1.0). Fastq 
files were aligned to the custom transcriptome, cell barcodes were demultiplexed, and UMIs 
corresponding to genes were counted using the cellranger count command and default 
parameters. 
Data Transformation for Secondary Analysis 
The unfiltered gene barcode matrices for each sample were loaded into R using the Read10X 
function in the Seurat R package (version 2.2.0, 2.3.0)19. Cell names were modified such that the 
subject name, batch, and biological condition were added to them. Seurat objects were created 
corresponding to each sample using the CreateSeuratObject function with the imported 
unfiltered gene-barcode matrices provided as the raw data. Individual Seurat objects for each 
sample were combined into one object using the MergeSeurat function sequentially. No filtering 
or normalization was performed up to this step. Since this is a single nucleus dataset, all 
mitochondrial genes that are transcribed from the mitochondrial genome were removed, along 
with genes not detected in any cell. 
Barcode and Gene Filtering 
Based on the distribution of nGene (total number of genes detected in each cell) for the total 
dataset (assessed by summary and hist R52 functions), barcodes that were associated with less 
than 110 detected genes were removed. Based on the distribution of nUMI (total numbers of 




multiplets rather than single nuclei, as there was a very sharp increase of nUMI from 16,393 at 
the 99.5th percentile to 102,583 at the maximum.  
Next, the distribution of nUMI for the remaining barcodes was fit with three normal 
distributions using the normalmixEM function from the mixtools53 package (Supplementary Fig. 
1c). The rationale was that, the filtered barcodes contain a population of low quality “noise” 
barcodes that have a very low nUMI on average, a population of non-neuronal cells that have an 
intermediate nUMI and a population of neuronal cells that have a high nUMI. Based on the 
fitting of the normal distributions, only the barcodes with a high probability (> 0.95) of belonging 
to either the putative “non-neuronal” or putative “neuronal” distributions, and a low probability 
(<0.05) of belonging to the “noise” distribution were retained for further analysis 
(Supplementary Fig. 1c-d). 78,886 cells and 30,062 genes were retained.   
Our custom filtering (Supplementary Fig. 1a-e, Supplementary Table 4) helped to increase the 
number of glial cells recovered. With an initial subset of 20 subjects, applying our custom 
filtering increased the total number of cells 1.8–fold but increased the number of non-neuronal 
cells by almost 6-fold (data not shown). After custom filtering the minimum numbers of genes 
and UMIs per nucleus were 254 and 340 respectively. 
Once nuclei were filtered, the percentages of mitochondrial reads associated with the retained 
barcodes were calculated although for quality control purposes those reads were not used 
during the filtering or downstream analysis (Supplementary Fig. 1f). Although the percentage of 
reads mapping to mitochondrially expressed genes is a more pertinent quality control 
parameter for single-cell rather than single nucleus approaches, contaminating mitochondrial 
reads often present a problem in single-nucleus protocols (pers. comm., Lake, B.B.). However, 




Data Processing and Dimensionality Reduction  
The UMI counts were normalized to 10,000 counts per cell and converted to log scale (Seurat 
function NormalizeData). The batch, condition, and subject information was added as metadata 
to the final Seurat object; nUMI and batch were regressed out using the ScaleData function. The 
Seurat FindVariableGenes function was used with default selections and cut-offs as follows: 
x.low.cutoff = 0.003, x.high.cutoff = 2, y.cutoff = 1. This resulted in a list of 2135 highly variable 
genes, which excludes lowly expressed genes (below 25th percentile), very highly expressed 
genes, and selects only the top 10 % of genes in terms of the scaled dispersion. These highly 
variable genes were used to calculate 100 principal components. Based on the PC elbow plot of 
the standard deviation of the PCs (Supplementary Fig. 2a), the first 50 PCs were retained for use 
in downstream analysis. 
Clustering by Gene Expression 
The FindClusters function was applied with a resolution of 2.5 and produced 44 initial clusters. 
The goal of clustering is to sort nuclei by cell type so that all remaining gene expression variation 
within clusters is not related to cell differentiation processes. Prior to the advent of single nuclei 
expression profiling, cell types were identified by observing differences in cell morphology, 
behaviour, and anatomic location. It is fairly straight-forward to sort single nuclei expression 
profiles into known cell types according to the expression levels of marker genes that 
differentiate between these cell types. However, it is very unlikely that all cell types have been 
identified so we must rely on nuclei clustering to uncover as-yet unknown cell types.  
Unfortunately, the number of clusters obtained from the clustering algorithm is somewhat 
arbitrary because clustering depends on the settings of several parameters, and there is no 




settings usually correspond to known biological cell types, some clusters may appear to 
potentially identify entirely new cell types or splinter existing cell types into multiple subtypes. 
Deciding if the clusters really do identify new cell types can be difficult or may even be 
impossible from available data. 
To address this issue, we used tools in the Seurat package to sequentially combine any clusters 
that were not sufficiently distinct from each other. In particular, after performing initial 
hierarchical clustering of the graph-based clusters (BuildClusterTree), we assessed the nodes of 
the dendrogram using a random forest classifier (AssessNodes) and then merged together any 
nodes which were in the bottom 25 % of the dendrogram (using the branching.times function 
from the ape R package54) and had an out-of-bag-error of more than 5 %. We then repeated this 
clustering and merging process for the nuclei within each terminal node until none of the 
remaining nodes fulfilled our cut-off criteria (Supplementary Fig. 2b). The resulting set of 30 
clusters were then characterized in terms of known markers genes of all major, well-defined 
brain cell types (Supplementary Fig. 2c-d). For refining identification of excitatory neuron types, 
we combined and re-clustered a set of excitatory clusters with highly correlated gene expression 
profiles (R > 0.95) (Supplementary Fig. 13a-c) using similar parameters for clustering as the 
whole dataset. This included 7 clusters of ~40,000 cells.  Reclustering yielded 33 final clusters for 
downstream analysis. Finally, the clusters were manually curated to eliminate potential biases; 
for example, clusters were removed if mainly one sample contributed to the cells contained 
within the cluster (Supplementary Tables 48-51, Supplementary Fig. 14a-e). 
Cluster Annotation 
Genes used as markers for major cell-types and layer-specificity are listed below. Inhibitory 




markers SST, PVALB, and VIP where possible. Excitatory neuron subtypes were annotated with 
some level of layer specificity based on expression of layer specific markers11, 55, 56. We also 
characterised clusters in terms of all genes differentially expressed between clusters 
(FindAllMarkers function, bimodal test, logfc.threshold of log(2), other parameters set to 
default) (Supplementary Table 6). 
Major cell-type markers (Supplementary Fig. 3a-p) 
Macrophage/ Microglia: SPI1, MRC1, TMEM119, CX3CR1; Endothelial: CLDN5, VTN; Astrocytes: 
GLUL, SOX9, AQP4, GJA1, NDRG2, GFAP, ALDH1A1, ALDH1L1, VIM; OPCs: PTGDS, PDGFRA, 
PCDH15, OLIG2, OLIG1; Oligodendrocytes: PLP1, MAG,MOG, MOBP, MBP; Excitatory neurons: 
SATB2, SLC17A7, SLC17A6; Inhibitory neurons: GAD1,GAD2, SLC32A1; Neurons: SNAP25,STMN2, 
RBFOX3. 
Layer-specific markers:  
L2: GLRA3; L2-3: LAMP5, CARTPT; L2-4: CUX2, THSD7A; L2-6: RASGRF2, PVRL3; L3-4: PRSS12; L4-
5: RORB; L4-6: GRIK4; L5: KCNK2, SULF2, PCP4, HTR2C, FEZF2; L5-6: TOX, ETV1, RPRM, RXFP1, 
FOXP2; L6: SYT6, OPRK1, NR4A2, SYNPR, TLE, NTNG2, ADRA2A 
 
Pseudotime trajectory using Monocle 
For oligodendrocyte developmental trajectory assessment, the data for cells belonging to the 
five clusters in the oligodendrocyte lineage (Oligos_1, Oligos_2, Oligos_3, OPCs_1, OPCs_2) were 
used to create a separate Seurat object using the SubsetData function. The most variable genes 
for these clusters alone were identified using the FindVariableGenes function and the following 
parameters: x.low.cutoff = 0.003, x.high.cutoff = 3, y.cutoff = 1 (giving a total of 895). The Seurat 




Estimation of size factors and dispersions was performed (using the estimateSizeFactors and 
estimateDispersions Monocle functions) on the CDS object using default parameters. 
Dimensionality reduction was then performed using reduceDimension, with reduction_method 
set to DDRTree. The 895 variable genes identified as above were used for ordering the cells into 
a trajectory with the orderCells function. The pseudotime trajectory was then plotted with 
plot_cell_trajectory (Fig. 2e), and the change in expression of genes known to be involved in 
oligodendrocyte development were plotted using plot_genes_in_pseudotime (Supplementary 
Fig. 6b-i). differentialGeneTest was applied separately to oligodendrocyte lineage cells from 
control subjects and MDD cases with fullModelFormulaStr = "~sm.ns(Pseudotime)". This allows 
us to model the expression of each gene as a function of pseudotime.  All genes detected in at 
least one cell in the respective group were compared and their changes across pseudotime were 
assessed. A q-value cut-off of < 0.01 was used to identify genes associated with pseudotime. The 
overlapping and non-overlapping genes were identified by comparing the lists obtained for the 
two groups (Supplementary Fig. 6a).  
Purification of Clusters for Differential Expression 
Our doublet removal approach comprised of calculating a median gene expression profile for all 
our clusters, calculating the correlation of the gene expression of each cell, with the median 
profile of its cluster (considering only the top 865 genes whose median expression was highly 
variable, that is had a variance of > 0.25 across the different cluster) and selecting cells with high 
correlation. This was done by fitting bimodal normal distributions to the total distribution of 
correlations in the cluster to identify low and high correlation peaks. Cells were retained only if 
they had a low probability of falling in the low correlation peak (p < 0.25) and a high probability 




Differential Gene Expression Analysis 
Differential expression analysis between the cases and controls was performed using linear 
mixed models implemented in the lme457 and lmerTest58 R packages. Mixed models were 
necessary in order to account for dependencies between nuclei obtained from the same subject. 
Biological condition and number of UMIs were included in models as fixed effects and the 
subject and batch as random effects. The inclusion of subject as a random effect should account 
for subject specific effects such as age and PMI as well as technical effects of capture and library 
preparation which was performed separately for each subject. A false discovery rate (FDR) of 0.1 
was used to detect differentially expressed genes within each cell type.  
Weighted Gene Co-expression Network Analysis (WGCNA) 
Average cell-expression for each sample across every cluster was calculated. These average 
counts were converted to log + 1 counts to reduce dispersion. WGCNA analysis was carried out 
in R with the WGCNA package (version 1.68) by Langfelder and Horvath. Genes with insufficient 
variance were excluded as well as outlier samples. After some tests, a soft-thresholding power 
of 7 and a minimum module size of 30 genes were selected for the gene network construction. 
Resulting modules were correlated with the phenotype information (MDD vs Control), as well as 
each sample's respective composition of each of the 26 single-cell type clusters they're 
composed of. 
We performed hub gene analysis on the blue module, which was the largest module (2699 
genes) which was correlated to phenotype. Potential hub genes were identified in the module of 
interest my selecting genes with a module membership larger than 0.80 and a gene significance 




alongside any weighted interaction of more than 0.2. The resulting network was visualized in 
Cytoscape (3.7.1). 
Fluorescence-assisted nuclei sorting (FANS) 
Nuclear suspensions were prepared from 80-100 mg of post-mortem brain tissue from BA9 as 
described previously 59 with the following modifications: homogenized tissue was centrifuged on 
the sucrose layer at 800g for 20 minutes at 4oC, followed by another centrifugation in nuclei 
extraction buffer. Resuspended nuclei were stained with the following primary antibodies in 600 
μL of blocking buffer: mouse anti-CUTL2-PerCP conjugated (1:100, Novus catalog no. 
H00023316-M03, clone 2H8, conjugated to PerCP using the Novus Lightning Link Labeling kit, 
catalog no. 718-0010), goat anti-SOX10 (1:100, R&D Systems catalog no. AF2864), mouse anti-
NeuN-A700 (1:300, Novus catalog no. NBP1-92693AF700, clone- 1B7) by incubating at room 
temperature, away from light, with rotation for 2 hours. Secondary antibody (donkey anti-goat 
Alexa Fluor 488, 1:1000, JacksonImmuno 705-545-147) was added and incubated for 1 hour at 
room temperature with rotation. All antibodies were purchased from Cedarlane. Nuclei were 
washed with PBS and the DNA was stained by Hoechst 33342 (Invitrogen, H1399).  
FACSAria Fusion (BD Biosciences, San Jose, CA) was used for sorting of four populations – SOX10 
positive, SOX10 negative, CUTL2 positive and CUTL2 negative. Gating strategy for the sorts is 
shown in (Supplementary Fig. 11) and was as follows. Doublet discrimination was achieved by 
gating of Hoechst 33342 stained singlets in FSC-A vs Hoechst-A plot using 350 nm UV laser and 
450/50 filter. Subsequent SOX10 positive, SOX10 negative and NeuN positive populations were 
gated in Alexa Fluor 700-A vs Alexa Fluor 488-A plot utilizing red 640 nm laser in combination 
with 730/45 filter and blue 488 laser in combination with 530/30 filter, respectively. CUTL2 




488-A vs PerCP-A (blue 488 laser, 695/40 filter) plot with interval gates. CUTL2 positive 
population was identified as 30-40% of NeuN positive population with highest CUTL2-PerCP 
fluorescence. For gating of CUTL2 negative population the SOX10 negative and SOX10 positive 
populations were displayed in Alexa 488-A vs PerCP-A plot and the CULT2 negative population 
was gated within PerCP intensities of SOX10 populations. CUTL2 negative population comprised 
near 10% of NeuN positive population. 
Validation information for antibodies is as follows: Novus H00023316-M03- validated in Western 
blot and ELISA, used in one publication in human brain tissue (PMID: 29126813); R&D Systems 
AF2864- validated in Western blot against human SOX10 protein, ELISAs, immunocytochemistry, 
19 citations; Novus NBP1-92693AF700- validated in immunocytochemistry, 
immunohistochemistry, Western blot, one publication for flow cytometry in human brain tissue 
(PMID: 28750583). 
High-throughput qPCR 
RNA was extracted from FANS sorted nuclei population using the Norgen RNA/DNA Purification 
Kit (Cat. 48700). cDNA was synthesized using a modified SMART-seq procedure as described 
previously 60. The Fluidigm Biomark system was used for performing high-throughput qPCR as 
per manufacturer protocol as previously described61. Fludigim Delta Gene™ primer designs were 
used for the 93 targets (all differentially expressed transcripts excluding AC133680.1) and 3 
endogenous controls (GAPDH, POLR2A, UBC).  
Cell-cell interaction measurement 
To assess cell-cell communication, we calculated predicted ligand-receptor interactions between 




between each ligand and receptor is quantified as an edge weight. We chose a gene expression 
threshold of 2.75 and above to limit our research to relatively highly expressed ligands and 
receptors and for ease of visualization. To test if the edge weights were significantly different 
between cases and controls, we randomly permuted our subjects into two groups 100 times and 
formed normal distributions of the edge weight differences between groups for each ligand-
receptor pair. We then calculated a p-value for the case-control edge weight difference for each 
ligand-receptor pair based on its position in the distribution. Edge weight difference p-values 
<0.01 were considered significant. A sample script used for assessing the significance of edges 
has been provided. 
Cell deconvolution for all clusters 
Expression data from (dbGaP:phs000424.v8.p1)11 was used as reference signatures for 
annotated cell types. UMI counts for each cell were converted to transcripts per million (TPMs) 
in order to account for the varying sequencing depth of each cell and sample. Average 
expression levels were calculated for each cell type-specific cluster defined in the paper. 
Cluster-specific gene expression profiles were obtained by summing the UMI values of all 24301 
genes common to our dataset and the reference for each nucleus in each cluster and converting 
the sums to TPMs. R package, DeconRNASeq v1.18.063 was used to deconvolute these cluster-
specific profiles. Using the data from11as reference, we were able to estimate the cell type 
composition of our clusters. 
Cell deconvolution for oligodendrocyte lineage  
Average expression from every control samples from the Jäkel et al. dataset were calculated and 




expression of every cell in the cluster considered as bulk) using the R package DeconRNASeq (v 
1.26.0). 
RNA-Scope Fluorescent In Situ Hybridization 
Frozen BA9 blocks were cut serially with a cryostat (10µm thickness) on superfrost charged 
slides and kept at -80oC until further processed. In situ hybridization was performed using 
Advanced Cell Diagnostics RNAscope® probes and reagents according to the manufacturer 
instructions in 5 matched subjects per group. Briefly, sections were first fixed in chilled 10% 
neutral buffered formalin for 15 mins at 4oC, dehydrated by increasing gradient of ethanol 
bathes and left to air dry for 5 minutes. Endogenous peroxidase activity was quenched with 
hydrogen peroxide reagent for 10 minutes, followed by protease digestion for 30 minutes at 
room temperature. The following sets of probes were then hybridized for 2 hours at 40oC in a 
humidity-controlled oven (HybEZ II, ACDbio): Hs-RXFP1 (cat. no. 422821), Hs-FIBP (cat. no. 
569781-C2) and Hs-SLC17A7 (cat. no. 415611-C3) to quantify FIBP expression in excitatory 
(SLC17A7+) layer 5-6 (RXFP1+) neurons; KAZN (cat. no. 569791) and PDGFRA (cat. no. 604481-
C3), and HSP90AA1 (cat. no. 477061)  to quantify KAZN expression in OPCs (PDGFRA+). 
Successive addition of amplifiers was performed using the proprietary AMP reagents, and the 
signal visualized through probe-specific HRP-based detection by tyramide signal amplification 
with Opal dyes (Opal 520, Opal 570 and Opal 690; Perkin Elmer) diluted 1:300. Slides were then 
coverslipped with Vectashield mounting medium with DAPI for nuclear staining (Vector 
Laboratories) and kept at 4oC until imaging.  
Imaging and analysis of in situ RNA expression 
Image acquisitions was performed on a FV1200 laser scanning confocal microscope (FV1200) 




were taken to capture at least 20 cells of interest per subject: excitatory neurons (SLC17A7+) 
from cortical layers 5-6 (RXFP1+), and OPCs (PDGFRA+). Images were taken using a x60 objective 
(NA = 1.42) with a XY pixel width of 0.3µm and Z spacing of 0.4µm. Laser power and detection 
parameters were kept consistent between subjects for each set of experiment. Because TSA 
amplification with Opal dyes yields a high signal to noise ratio, parameters were set so that 
autofluorescence from lipofuscin and cellular debris was filtered out of the image. Positivity for 
cell defining markers was determined by bright clustered puncta-like signal present within the 
nucleus and cytoplasm of the cells. Expression of genes of interest was quantified using the 
“Analyze Particles” function in Fiji 64. Stacks were first converted to Z-projections, and for each 
image cell nuclei of cells of interests were manually contoured based on DAPI expression. Single 
labeled molecules of RNA were automatically counted in each channel using the find maxima 
function with a noise tolerance of 350 for FIBP and RXFP1, and 400 for KAZN and PDGFRA. 
Normalized FIBP and KAZN expression per cell was calculated by dividing FIBP and KAZN raw 
counts to RXFP1 and PDGFRA raw counts respectively. HSP90AA1 expression was quantified by 
manually thresholding the signal per image and measuring the percentage of area of the nucleus 
covered by the resulting mask. 
Statistical analysis 
No statistical methods were used to predetermine sample size. Sample size was determined 
based on sample sizes used in previous similar studies. Subjects were assigned to groups based 
on diagnosis and not by random assignment. All subjects were male, and groups were matched 
for age (18-87 years), post-mortem interval (12-93 hours), and brain pH (6-7.01). Clinicians were 




gene expression profiles was performed in an unbiased blinded manner. Cluster annotations 
were assigned after generation of clusters.  
Clusters were excluded from downstream analysis if they did not show even contribution from 
subjects as these clusters are likely to reflect sample specific artifacts rather than biological 
variability of interest. Single-nuclei were excluded from cell-type clusters based on their level of 
correlation to the median expression profile of the cluster (lowly correlated nuclei were 
removed) as detailed above to ensure that differential gene expression analysis was performed 
using similar nuclei populations from cases and controls. The exclusion criteria were not pre-
established and were chosen based on preliminary analysis of the data. 
Differential expression analysis between the cases and controls in the snRNA-seq data was 
performed using linear mixed models implemented in the lme457 and lmerTest58 R packages 
with biological condition and number of UMIs as fixed effects, the subject and batch as random 
effects, and a false discovery rate of 0.1 for significance. All DEGs from this analysis were also 
significantly differentially expressed between cases and controls when re-tested using two-
tailed Wilcoxon tests (Supplementary Table 52). For analysis of RNAScope results, two-tailed t-
tests were performed with a significance threshold of p < 0.05 and data distribution was 
assumed to be normal but this was not formally tested. For analysis of high-throughput qPCR 
data two-tailed t-tests or two-tailed Wilcoxon rank sum (i.e. Mann Whitney U tests) were 
performed, both at a significance threshold of p <0.05, and depending on data normality as 
measured by the Shapiro Wilk’s test. The results in Supplementary Tables 43-46 are for genes 





Raw sequencing data, annotated gene-barcode matrix, and lists of cells used for differential 
gene expression analysis are accessible on GEO using the accession number GSE144136 or using 
this link: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144136. RNAScope and high-
throughput qPCR data are available upon request.  
Code Availability 
A sample custom R script (Supplementary_R_Script_1.R) used for analyzing high-throughput 
qPCR data is provided and an R script used to test the statistical significance of CCInx 
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